Osterweis Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-149,591
Closed -$7.7M 295
2025
Q2
$7.7M Sell
149,591
-117,100
-44% -$5.88M 0.37% 68
2025
Q1
$15.6M Buy
266,691
+20,960
+9% +$1.42M 0.77% 47
2024
Q4
$17.7M Buy
245,731
+76,288
+45% +$5.6M 0.82% 44
2024
Q3
$13.5M Sell
169,443
-3,070
-2% -$231K 0.69% 49
2024
Q2
$12.4M Buy
172,513
+50,185
+41% +$3.69M 0.64% 43
2024
Q1
$8.61M Buy
+122,328
New +$8.75M 0.51% 56
2021
Q2
Sell
-102,680
Closed -$9.8M 148
2021
Q1
$9.8M Sell
102,680
-19,120
-16% -$1.74M 0.53% 58
2020
Q4
$9.67M Buy
121,800
+28,080
+30% +$2.03M 0.58% 52
2020
Q3
$5.8M Buy
93,720
+9,040
+11% +$588K 0.39% 65
2020
Q2
$5.59M Sell
84,680
-400
-0.5% -$24K 0.41% 64
2020
Q1
$4.03M Sell
85,080
-30,640
-26% -$1.53M 0.33% 64
2019
Q4
$6.35M Buy
+115,720
New +$6.07M 0.44% 51
2019
Q3
Sell
-60,440
Closed -$3.15M 118
2019
Q2
$3.15M Sell
60,440
-119,300
-66% -$6.01M 0.22% 76
2019
Q1
$8.92M Buy
179,740
+30,180
+20% +$1.36M 0.56% 53
2018
Q4
$5.41M Sell
149,560
-4,660
-3% -$195K 0.42% 60
2018
Q3
$7.87M Buy
154,220
+33,360
+28% +$1.48M 0.5% 59
2018
Q2
$4.47M Sell
120,860
-84,000
-41% -$3.21M 0.29% 75
2018
Q1
$7.74M Buy
204,860
+33,380
+19% +$1.18M 0.55% 45
2017
Q4
$5.55M Buy
171,480
+36,200
+27% +$1.15M 0.39% 44
2017
Q3
$4.09M Buy
135,280
+36,180
+37% +$1.07M 0.31% 49
2017
Q2
$2.91M Buy
+99,100
New +$2.71M 0.22% 60

Other funds holding TECH

Osterweis Capital Management's TECH Position: Q3 2025 in Review

Osterweis Capital Management sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 149,591 shares — an estimated $7.7M sold.

Osterweis Capital Management first reported a position in TECH in Q2 2017 and held it in 21 quarters. The position peaked at $17.7M in Q4 2024. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • Osterweis Capital Management reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • Osterweis Capital Management sold 149,591 Bio-Techne shares in Q3 2025, an estimated $7.7M.
  • Osterweis Capital Management first reported a position in Bio-Techne in Q2 2017 and held it in 21 quarters.
  • Osterweis Capital Management's Bio-Techne position peaked at $17.7M in Q4 2024.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Osterweis Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.